Denials and Cash-Pay Options

How to respond to a denial, what self-pay actually costs today, and exactly what to ask your plan.

Information current as of July 30, 2026. Coverage rules for these medications change frequently — several major Virginia plans changed their rules on July 1, 2026. Always confirm details with your own plan before making decisions.

Before appealing, confirm which of the two coverage gates stopped you — it determines whether an appeal can work at all.

If you’re denied

Find out which gate you failed. A denial for “benefit exclusion” means your plan doesn’t cover this category at all — appealing the clinical criteria won’t help. A denial for not meeting clinical criteria can often be fixed.

Get the denial in writing and read the specific reason. Common fixable reasons include missing documentation of lifestyle attempts, missing height and weight from within the required window, a comorbidity that wasn’t submitted, or an undocumented step-therapy requirement.
Ask about the backdoor. Sleep apnea, type 2 diabetes, cardiovascular disease, or MASH may qualify you under a pathway weight-loss exclusions don’t govern.
Check the formulation. Pen versus KwikPen versus vial can be the entire problem.
File an internal appeal, then an external review. In Virginia, external review is available through the State Corporation Commission Bureau of Insurance for state-regulated plans; self-funded employer plans follow federal rules.
Have your prescriber call. A peer-to-peer review often resolves denials that paperwork alone doesn’t.

If you’re paying cash

Manufacturer direct-pay programs have become a genuine alternative, particularly for people whose plans exclude these drugs.

Zepbound. Lilly offers self-pay pricing on the KwikPen through LillyDirect and, as of March 2026, at major pharmacies nationwide — starting at $299/month for 2.5 mg, $399 for 5 mg, and $449 for higher doses, with prices tied to refilling within a set window.

Wegovy. Through NovoCare Pharmacy, self-pay pricing for the Wegovy pen starts at $199/month for the two lowest doses for new patients (a limited-time rate through December 31, 2026), then $349/month. Wegovy HD is $399/month; the Wegovy pill starts at $149/month for certain doses. Patients with commercial insurance may pay as little as $25/month through the savings offer, subject to a $100/month maximum savings.

Two important limits on savings cards. Money spent through self-pay programs does not count toward your deductible or out-of-pocket maximum. And people with government insurance — Medicare, Medicaid, TRICARE — generally cannot use commercial copay cards, though they may pay the self-pay price outside their insurance. Novo Nordisk notes that FEHB, marketplace, and state employee plans are not treated as government programs for purposes of its savings offer.

Prices and program terms change often. Verify current pricing directly with the manufacturer.

If long-term medication cost is the obstacle, it’s worth comparing against surgical weight-loss options, which most Virginia plans do cover.

Questions to ask your plan

Call the member services number on your card and ask:

Does my plan cover prescription weight-loss medications at all, or are they excluded? Ask them to state it clearly.
Is Zepbound, Wegovy, or Saxenda on my formulary, and what tier?
What BMI does my plan require, and does a weight-related condition lower that threshold?
How many months of documented lifestyle changes do I need, and what counts as documentation?
Do I have to try a different weight-loss drug first?
Which formulation is covered — pen, KwikPen, or vial?
If weight-loss drugs are excluded, is the same medication covered for another condition I have — sleep apnea, type 2 diabetes, heart disease, or fatty liver disease?
How long does an initial approval last, and what do I need to show to renew?
What’s my actual monthly cost after the deductible?

Let us help

Our staff verifies benefits and submits prior authorizations every week, and we know which documentation each Virginia plan actually wants. Contact our office and we’ll walk through your plan with you.

Frequently asked questions

What should I do if I am denied?

Find out which gate you failed. A benefit exclusion denial cannot be fixed by clinical appeal, so cash-pay is the realistic path. A clinical-criteria denial often can be fixed: submit missing lifestyle documentation, recent height and weight, or an overlooked comorbidity; check whether a different formulation (pen versus KwikPen versus vial) is the covered one; file an internal appeal and then external review; and ask your prescriber for a peer-to-peer review.

What does weight-loss medication cost if I pay cash?

Manufacturer direct-pay programs have become a genuine alternative. Zepbound self-pay through LillyDirect and major pharmacies starts around $299/month for 2.5 mg, $399 for 5 mg, and $449 for higher doses. Wegovy through NovoCare Pharmacy starts at $199/month for the two lowest doses for new patients, then $349/month, with the pill starting at $149/month. Self-pay dollars do not count toward your deductible or out-of-pocket maximum.

Other coverage guides

Virginia Medicaid & state employeesCardinal Care’s strict BMI rules, and the July 2026 COVA change to a BMI of 35.Medicare, TRICARE & federal employeesThe $50 Medicare GLP-1 Bridge, TRICARE step therapy, and FEHB requirements.Employer, commercial & marketplace plansSentara, UnitedHealthcare, Cigna, Anthem, Aetna, your PBM, and why marketplace plans exclude these drugs.

Not sure where you stand?

Our team helps patients verify benefits and submit prior authorizations every day. Start with a consultation and we’ll work through your plan’s requirements together.

Request a consultation Weight-loss medications